![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 30, 2002
J. Biol. Chem, 10.1074/jbc.M200956200
Submitted on January 29, 2002
Revised on January 30, 2002
Accepted on January 29, 2002
Department of Molecular Immonology, Tel Aviv University, Medical School, Petach-Tikva 49100
Corresponding Author: hmoroz{at}post.tau.ac.il
Ferritin is a ubiquitous iron storage protein existing in multiple isoforms composed of 24 heavy and light chain subunits. We describe here a third ferritin-related subunit cloned from human placenta cDNA library and named PLIF. PLIF coding region is composed of ferritin heavy chain (FTH) sequence lacking the 65 C-terminal amino acids, which are substituted with a novel 48 amino acid domain (C48). In contrast to FTH, PLIF mRNA does not include the iron-responsive element (IRE) in the 5-UTR, suggesting that PLIF synthesis is not regulated by iron. The linkage between the FTH and C48 domains created a restriction site for EcoRI. PLIF protein was found to localize in syncytiotrophoblasts of 8 weeks placentas at the fetal-maternal interface. Increased levels of PLIF transcript and protein were also detected in the breast carcinoma cell lines T47D and MCF-7 but not in the benign corresponding cell line HBL-100. In-vitro, PLIF was shown to down modulate mixed lymphocyte reactions and to inhibit the proliferation of peripheral blood mononuclear cells stimulated with OKT3. The accumulated data indicate that PLIF is an embryonic immune factor involved in down-modulating the maternal immune recognition of the embryo toward anergy. This mechanism may have been adapted by breast cancer cells over expressing PLIF.
This article has been cited by other articles:
![]() |
R. Nahum, O. Brenner, M.A. Zahalka, L. Traub, F. Quintana, and C. Moroz Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome Hum. Reprod., March 1, 2004; 19(3): 715 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maymon, E. Jauniaux, and C. Moroz Enhanced expression of the immunoregulator, p43-placental isoferritin, in Down's syndrome placentae and fetal kidneys Mol. Hum. Reprod., December 1, 2002; 8(12): 1125 - 1128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |